方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 成本效益分析 (CBA)× | 卫生经济学中的决策分析模型× | |
|---|---|---|
| 领域 | 卫生经济学 | 卫生经济学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1970s | 1975 |
| 提出者≠ | Boardman, Greenberg, and colleagues (welfare economics) | Pauker & Kassirer (medical decision analysis, Massachusetts General Hospital) |
| 类型 | Method | Method |
| 开创性文献≠ | Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press. link ↗ | Pauker, S. G., & Kassirer, J. P. (1975). Therapeutic Decision Making: A Cost-Benefit Analysis. New England Journal of Medicine, 293(5), 229-234. DOI ↗ |
| 别名≠ | CBA, economic appraisal, benefit-cost ratio | decision analysis, decision tree, decision model, health economic model |
| 相关 | 5 | 5 |
| 摘要≠ | Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types. | Decision analytic modeling is a systematic framework for comparing health interventions by integrating evidence on probabilities, outcomes, costs, and patient preferences into a quantitative model. Developed by Pauker and Kassirer in 1975, decision analysis structures clinical uncertainty and economic trade-offs, enabling transparent comparison of treatment options and identification of optimal strategies. Used in health technology assessment, clinical practice guideline development, and resource allocation decisions. |
| ScholarGate数据集 ↗ |
|
|